Boston Scientific is releasing in Europe three new cardiac pacemakers featuring RightRate technology that monitors the patient’s breathing to help adjust the pulses delivered to the heart. The lineup comprises an INLIVEN cardiac resynchronization therapy pacemaker (CRT-P) and VITALIO and FORMIO pacemakers.
Each one also includes Boston Sci’s AP Scan technology that helps clinicians monitor and manage patients with sleep apnea, a common comorbidity in those with pacemakers, and wireless data sharing so that readings can be gathered from the implants at home and sent to a cardiologist for review. Some of the new devices are MR-conditional, meaning an MRI scan can be performed on patients wearing them as long as certain precautions are taken by the techs.
More from Boston Sci:
In addition, FORMIO includes a full range of features that monitor, track and trend physiological markers related to heart failure, making this device specifically suited to assist in diagnosing patients who are at higher risk of heart failure. These can include those with atrio-ventricular block, a condition in which there is a longer-than-normal delay between the contractions of the heart’s chambers. With AP Scan, Respiratory Rate Trend, Heart Rate Variability diagnostics and remote home monitoring via the LatitudeTM NXT system, FORMIO may help physicians detect changes earlier and make proactive decisions, with the aim of positively impacting clinical outcomes.
“The new family of devices is able to offer a unique perspective on the patient’s pacing status by monitoring cardio-respiratory signals for broader co-morbidity management,” said Jean-Benoît Le Polain de Waroux, professor, Cliniques Universitaires Saint-Luc in Brussels, Belgium, and an investigator in the approval studies for the devices. “The technology is able to adapt the pacing rate to meet the patient’s metabolic needs when his or her respiration is increasing, as during exercise.”